Charli XCX borrows Role Model's Kansas City t-shirt for her 'Saturday Night Live' cameo as Sally. Rosalind O'Connor/NBC/Will Heath/NBC As Charli XCX made a surprise cameo during Role Model‘s ...

OpenAI’s Sora app has gone viral for letting users create AI-generated videos of themselves. But what does it do with your facial data? Can you delete your account if you change your mind? OpenAI ...

Meta’s AI research team has released a new large language model (LLM) for coding that enhances code understanding by learning not only what code looks like, but also what it does when executed. The ...

It seems like everyone wants to get an AI tool developed and deployed for their organization quickly—like yesterday. Several customers I’m working with are rapidly designing, building and testing ...

The biggest stories of the day delivered to your inbox.

The reinsurance industry is built on data. Weather and climate data, according to Frank Nutter (pictured), president of the Reinsurance Association of America, isn’t coming from private labs or ...

Visual Studio Code includes built-in integration with GitHub Copilot and the ability to choose which AI model to use for code completions. But the latest Visual Studio Code version adds a new ...

Predictive maintenance success depends on more than just data collection—it requires accurate interpretation, expert engineering input, and alignment between digital insights and real plant conditions ...

Mechatronic Systems Laboratory, Institute of Machine Design and Systems Technology, Technische Universität Berlin, Berlin, Germany This paper presents the development and experimental validation of a ...

As large language models (LLMs) continue to improve at writing code, a key challenge has emerged: enabling them to generate complex, high-quality training data that actually reflects real-world ...

Upstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology Congress highlighting the advantages of verekitug, a treatment targeting the TSLP receptor, over tezepelumab, ...